Company: LIMN
Filing Date: 2025-06-02
Form Type: 10-Q
Source: 0001410578-25-001388
Chunk: 6

Company: Liminatus Pharma, Inc.
Filing Date: 2025-06-02
Form: 10-Q
Item: Part II, Item 3D
Chunk 6
---
Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

None.

Item 6. Exhibits.

The following exhibits are filed as part of, or incorporated by reference into, this report:

No.    Description of Exhibit31.1​Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) under the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes Oxley Act of 2002.32.1*​Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.101.INS​XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document101.SCH​XBRL Taxonomy Extension Schema Document101.CAL​XBRL Taxonomy Extension Calculation Linkbase Document101.DEF​XBRL Taxonomy Extension Definition Linkbase Document101.LAB​XBRL Taxonomy Extension Labels Linkbase Document101.PRE​XBRL Taxonomy Extension Presentation Linkbase Document104​Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

​

*Furnished herewith

​

​